Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 1/20 | 0.52 |
| ▸ | GRM2 | Q14416 | 7/20 | 0.48 |
| ▸ | CALML3 | P27482 | 3/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | FADS1 | O60427 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2896810 | 1.00 | F10 (0.52) | F10GRM2CALML3MAOAMAOB | |
| SCHEMBL6233611 | 0.85 | GRM2 (0.66) | F10GRM2CALML3MAOAMAOB | |
| SCHEMBL2896939 | 0.85 | GRM2 (0.66) | F10GRM2CALML3MAOAMAOB | |
| SCHEMBL3430334 | 0.84 | MAOA (0.58) | GRM2CALML3MAOAMAOBFADS1 | |
| SCHEMBL3430331 | 0.84 | MAOA (0.58) | GRM2CALML3MAOAMAOBFADS1 | |
| SCHEMBL8594735 | 0.84 | GRM2 (0.48) | F10GRM2CALML3MAOAMAOB | |
| SCHEMBL12956131 | 0.84 | F10 (0.49) | F10GRM2CALML3MAOAMAOB | |
| SCHEMBL3368977 | 0.84 | F10 (0.49) | F10GRM2CALML3MAOAMAOB | |
| SCHEMBL3368973 | 0.84 | F10 (0.49) | F10GRM2CALML3MAOAMAOB | |
| SCHEMBL16701334 | 0.81 | BPTF (0.57) | F10GRM2CALML3MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100286211-A1 | OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS | RANBAXY LABORATORIES LIMITED (IN) | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286211-A1 | OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS | OXA1L, PDK4, MLYCD | F10 1709/4885GRM2 3646/4885CALML3 3047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.